A detailed history of Eagle Claw Capital Managment, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Eagle Claw Capital Managment, LLC holds 18,531 shares of JNJ stock, worth $3 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
18,531
Previous 18,531 -0.0%
Holding current value
$3 Million
Previous $2.93 Million 7.61%
% of portfolio
0.5%
Previous 0.54%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $93,132 - $97,644
600 Added 3.35%
18,531 $2.93 Million
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $45,864 - $50,047
315 Added 1.79%
17,931 $2.81 Million
Q3 2023

Nov 07, 2023

BUY
$155.75 - $174.48 $15,575 - $17,448
100 Added 0.57%
17,616 $2.74 Million
Q2 2023

Aug 09, 2023

SELL
$154.35 - $166.11 $54,022 - $58,138
-350 Reduced 1.96%
17,516 $2.9 Million
Q1 2023

May 04, 2023

BUY
$151.05 - $180.26 $9,818 - $11,716
65 Added 0.37%
17,866 $2.77 Million
Q4 2022

Feb 09, 2023

BUY
$160.2 - $179.79 $9,612 - $10,787
60 Added 0.34%
17,801 $3.14 Million
Q4 2022

Feb 06, 2023

SELL
$160.2 - $179.79 $9,612 - $10,787
-60 Reduced 0.34%
17,741 $3.13 Million
Q3 2022

Nov 07, 2022

SELL
$161.33 - $179.52 $46,785 - $52,060
-290 Reduced 1.6%
17,801 $2.91 Million
Q2 2022

Aug 08, 2022

SELL
$168.19 - $186.01 $29,433 - $32,551
-175 Reduced 0.96%
18,091 $3.21 Million
Q1 2022

May 13, 2022

SELL
$158.14 - $179.59 $11,860 - $13,469
-75 Reduced 0.41%
18,266 $3.24 Million
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $128,642 - $142,733
825 Added 4.71%
18,341 $3.14 Million
Q3 2021

Nov 05, 2021

BUY
$161.5 - $179.47 $54,425 - $60,481
337 Added 1.96%
17,516 $2.83 Million
Q2 2021

Aug 10, 2021

BUY
$159.48 - $171.07 $288,658 - $309,636
1,810 Added 11.78%
17,179 $2.83 Million
Q1 2021

May 12, 2021

BUY
$153.07 - $170.48 $38,267 - $42,620
250 Added 1.65%
15,369 $2.52 Million
Q4 2020

Feb 11, 2021

SELL
$137.11 - $157.38 $47,988 - $55,083
-350 Reduced 2.26%
15,119 $2.38 Million
Q3 2020

Nov 09, 2020

SELL
$140.38 - $153.83 $32,989 - $36,150
-235 Reduced 1.5%
15,469 $2.3 Million
Q2 2020

Aug 13, 2020

SELL
$128.81 - $155.51 $473,376 - $571,499
-3,675 Reduced 18.96%
15,704 $2.2 Million
Q1 2020

May 08, 2020

BUY
$111.14 - $153.99 $6,112 - $8,469
55 Added 0.28%
19,379 $2.54 Million
Q4 2019

Jan 27, 2020

BUY
$127.5 - $146.44 $312,375 - $358,778
2,450 Added 14.52%
19,324 $2.82 Million
Q3 2019

Oct 22, 2019

BUY
$126.95 - $142.14 $396,718 - $444,187
3,125 Added 22.73%
16,874 $2.18 Million
Q2 2019

Jul 18, 2019

SELL
$131.15 - $144.24 $68,853 - $75,726
-525 Reduced 3.68%
13,749 $1.92 Million
Q1 2019

May 01, 2019

BUY
$125.72 - $139.79 $98,564 - $109,595
784 Added 5.81%
14,274 $2 Million
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $9,458 - $11,383
77 Added 0.57%
13,490 $1.74 Million
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $2,188 - $2,571
18 Added 0.13%
13,413 $1.86 Million
Q1 2018

May 18, 2018

BUY
$125.1 - $148.14 $100,080 - $118,511
800 Added 6.35%
13,395 $1.72 Million
Q4 2017

Feb 13, 2018

BUY
$131.22 - $143.62 $249,449 - $273,021
1,901 Added 17.78%
12,595 $1.76 Million
Q2 2017

Aug 15, 2017

BUY
N/A
10,694
10,694 $1.41 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $424B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Eagle Claw Capital Managment, LLC Portfolio

Follow Eagle Claw Capital Managment, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Claw Capital Managment, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Claw Capital Managment, LLC with notifications on news.